Clinical Trial Update: Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With Radiochemotherapy [Phase 2]

View source ↗

Summary

A Phase II randomized study evaluating escalated, individualized radiochemotherapy for locally advanced non-small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Ass. Prof. Jan Nyman | Conditions: Non Small Cell Lung Cancer, Locally Advanced Disease | Phase 2 | Status: TERMINATED